Shenzhen Hwagen Pharmaceutical

CAS 13036-57-2

Chemistry, 1 End Use API, 14 Related Intermediates

Manufacturers/Suppliers

1 Suppliers

1 Suppliers

Also known as: 13036-57-2, 2-chloro-4-methyl-pyrimidine, Pyrimidine, 2-chloro-4-methyl-, Mfcd00054434, 4-methyl-2-chloropyrimidine, Chloro-6 methylpyrimidine

Molecular Formula

C₅H₅ClN₂

Molecular Weight

128.56 g/mol

InChI Key

BHAKRVSCGILCEW-UHFFFAOYSA-N

1 2D Structure

CAS 13036-57-2

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-chloro-4-methylpyrimidine

2.1.2 InChI

InChI=1S/C5H5ClN2/c1-4-2-3-7-5(6)8-4/h2-3H,1H3

2.1.3 InChI Key

BHAKRVSCGILCEW-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC1=NC(=NC=C1)Cl

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 13036-57-2

2. 2-chloro-4-methyl-pyrimidine

3. Pyrimidine, 2-chloro-4-methyl-

4. Mfcd00054434

5. 4-methyl-2-chloropyrimidine

6. Chloro-6 Methylpyrimidine

7. 2-chloro-4-methyl Pyrimidine

8. 4-methyl-2-chloro-pyrimidine

9. Schembl108558

10. 4-methyl-2-pyrimidinylchloride

11. Dtxsid40469672

12. Bhakrvscgilcew-uhfffaoysa-n

13. Cs-d1513

14. 2-chloro-4-methylpyrimidine, 97%

15. Sc2231

16. Akos000283811

17. Ac-6943

18. Fa-0251

19. Pb14106

20. 2-chloro-4-methylpyrimidine, Aldrichcpr

21. Sy005393

22. Am20080213

23. C2631

24. Ft-0600383

25. En300-66622

26. W-201031

27. Z1065586248

2.3 Create Date

2006-10-26

3 Chemical and Physical Properties

Molecular Formula	C₅H₅ClN₂
Molecular Weight	128.56 g/mol
XLogP3	1.6
Hydrogen Bond Donor Count	0
Hydrogen Bond Acceptor Count	2
Rotatable Bond Count	0
Exact Mass	g/mol
Monoisotopic Mass	g/mol
Topological Polar Surface Area	25.8
Heavy Atom Count	8
Formal Charge	0
Complexity	76.8
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

List of Suppliers

Full Screen View

Reset Filter

Ask Us

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

China

Virtual Booth

Digital Content

Methyl 3-((2,6-difluorophenyl)sulfonamido)-2-fluorobenz...

PDF Supplier PDF

URL Supplier Web Content

CAS Number

1195768-19-4

End Use API

Dabrafenib Mesylate

About the Company

Shenzhen HwaGen Pharmaceutical Co., Ltd. (HwaGen Pharma) was founded in December of 2015 under the leader...

Shenzhen HwaGen Pharmaceutical Co., Ltd. (HwaGen Pharma) was founded in December of 2015 under the leadership of a “National 1000 Talents Program” expert. By leveraging its core competency in chiral synthesis, enzymatic catalysis and continuous flow micro reactor, HwaGen Pharmaceutical is dedicated to development and manufacturing of specialty and niche intermediates and APIs covering various therapeutic areas including oncology, antiviral and respiratory, delivering high value-added and affordable products for global pharmaceutical industry. Equipments for Analysis & Test include Tabletop NMR, LC-MS, GC, HPLC etc.

ASK
US